Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine oral dissolvable tablets for cancer-related xerostomia
ACTRN12619000697189Phase 3Completed
- Sponsor
- Mater Misericordiae University Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pilocarpine in xerostomia, sponsored by Mater Misericordiae University Hospital. Primary endpoints: Feasibility completion endpoint and Participant diary composite assessments. Started Jul 2020; status: completed.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on ACTRN12619000697189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000697189.